The Freesolve BTK RMS is designed for patients auffering From chronic limb-threatening ischemia (CLTI)
March 20, 2024
FDA Breakthrough Device Designation for Biotronik Freesolve Below-the-Knee Resorbable Magnesium Scaffold (RMS)
March 20, 2024 — Biotronik has been granted Breakthrough Device Designation (BDD) from the US Food and Drug…
Read More
Cardiac CT isn't just a diagnostic tool — it's an essential component of cardiovascular health
By Alberto Morales, MD
March 20, 2024
Embracing Cardiac Imaging: Overcoming Barriers, Adopting In-house Solutions, and Navigating Future Advancements
Cardiac CT scans, recommended by the American College of Cardiology (ACC) and the American Heart Association (AHA) as…
Read More
ACC announces 2024 – 2025 Selected Learners for the CTR Program and new REACH cohort
March 19, 2024
ACC Clinical Trials Research Program REACH(es) New Heights
March 19, 2024 — The American College of Cardiology (ACC) has selected 50 learners for its 2024 – 2025 Clinical Trials…
Read More
Merger to create publicly-listed, commercial-stage leader in hybrid intravascular imaging
March 19, 2024
Titan Announces Merger Agreement with Conavi
March 19, 2024 — Titan Medical Inc. announced that it has entered into a definitive amalgamation agreement (the “…
Read More
A clinical trial at Cedars-Sinai is testing the safety and efficacy of a device aimed at managing treatment-resistant hypertension. Photo by Getty.
March 18, 2024
Cedars-Sinai Experts Studying Device for Controlling Treatment-Resistant Hypertension
March 18, 2024 — The Smidt Heart Institute at Cedars-Sinai recently became one of four institutions in the U.S. and the…
Read More
The first mitral valve replacement using the made in India SSi Mantra Surgical Robotic System was successfully performed at the Narayana Institute of Cardiac Sciences in Bengaluru, India
March 18, 2024
SS Innovations’ SSi Mantra Surgical Robotic System used to perform Mitral Valve Replacement
March 18, 2024 — SS Innovations International, Inc., a developer of innovative surgical robotic technologies dedicated…
Read More
Visual Thrombus Assessment as presented by Dr. William Gray at the Cardiovascular Research Technologies (CRT) 2024 conference.
March 18, 2024
Conformal Medical's CLAAS System Demonstrates Low Thrombogenicity Compared to Commercially Available LAAO Devices
March 18, 2024 — Conformal Medical, Inc. announced that the CLAAS System was featured in a podium presentation at the…
Read More
Biotronik Launches Its Complete Conduction System Pacing (CSP) Solution Consisting of the World’s First Approved CSP System Alongside Comprehensive Training and Expert Support
March 15, 2024
Biotronik Introduces World’s First and Only System CE Approved for Left Bundle Branch Area Pacing (LBBAP)
March 15, 2024 —  Following the recent CE approval of the Solia S lead1 for LBBAP, BIOTRONIK proudly announces the…
Read More
Partnership targets heart failure, the leading cause of death and a condition with limited treatment options
March 15, 2024
BioCardia and StemCardia Announce Biotherapeutic Delivery Partnership
March 15, 2024 —  BioCardia, Inc. , a biotechnology company focused on advancing late-stage cell therapy interventions…
Read More
Partnership targets heart failure, the leading cause of death and a condition with limited treatment options
March 15, 2024
Gilbert H. L. Tang Appointed Editor-in-Chief of JACC: Case Reports
March 15, 2024 —Renowned cardiovascular surgeon Gilbert H. L. Tang, MD, has been named Editor-in-Chief of JACC: Case…
Read More
Biotronik Launches Its Complete Conduction System Pacing (CSP) Solution Consisting of the World’s First Approved CSP System Alongside Comprehensive Training and Expert Support
March 15, 2024
Biotronik Introduces World’s First and Only System CE Approved for Left Bundle Branch Area Pacing (LBBAP)
March 15, 2024 —  Following the recent CE approval of the Solia S lead1 for LBBAP, Biotronik announces the world’s…
Read More
Partnership targets heart failure, the leading cause of death and a condition with limited treatment options
March 15, 2024
BioCardia and StemCardia Announce Biotherapeutic Delivery Partnership
March 15, 2024 —  BioCardia, Inc., a biotechnology company focused on advancing late-stage cell therapy interventions…
Read More
Partnership targets heart failure, the leading cause of death and a condition with limited treatment options
March 15, 2024
Gilbert H. L. Tang Appointed Editor-in-Chief of JACC: Case Reports
March 15, 2024 —Renowned cardiovascular surgeon Gilbert H. L. Tang, MD, has been named Editor-in-Chief of JACC: Case…
Read More
In a new letter sent to federal officials on March 12, the American Medical Association (AMA) has presented six relief proposals to support physicians impacted by Change Healthcare hack, and praised the creation of the Change Healthcare/Optum Payment Disruption (CHOPD) Accelerated Payments.
March 14, 2024
AMA Presents Relief Proposals to Federal Officials to Support Physicians Impacted by Change Healthcare Hack
March 14, 2024 — The American Medical Association (AMA) has issued a new letter to federal officials in which it…
Read More
First-of-its-kind trial in US shows drug-coated balloons are a superior treatment option for patients undergoing coronary angioplasty
March 13, 2024
BIDMC-led Trial Leads to FDA approval of Coronary Drug-coated Balloons
March 13, 2024 — In the largest randomized clinical trial and first of its kind to date in the United States, a team…
Read More
BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced Centers for Medicare & Medicaid Services (CMS) approval for reimbursement coverage of the confirmatory Phase III clinical trial of CardiAMP autologous cell therapy for the treatment of patients with ischemic heart failure.
March 13, 2024
BioCardia Announces CMS Approval of Coverage for CardiAMP Cell Therapy Confirmatory Phase III Heart Failure Study
March 13, 2024 —  BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of…
Read More
New Jersey-based Atlantic Health System’s Morristown Medical Center and New York-based NYU Langone Health, both nationally recognized cardiovascular programs, have announced that they are expanding their partnership to provide patients improved access to adult congenital heart disease services and the specialist directed care. Shown here, Trish O’Keefe, Senior Vice President, and President of Morristown Medical Center.
March 13, 2024
Atlantic Health System’s Morristown Medical Center and NYU Langone Health Expand Partnership to Include Adult Congenital Heart Disease
March 13, 2024 — Two nationally recognized cardiovascular programs, New Jersey-based Atlantic Health System’s…
Read More
Silence Therapeutics has announces positive topline 36-week data from its ongoing Phase 2 Study of Zerlasiran in patients with high Lipoprotein(a), reporting that the study met the primary endpoint and demonstrated highly significant reductions in Lp(a) to week 36.
March 13, 2024
Positive Topline 36-Week Data from Ongoing Phase 2 Study of Zerlasiran in Patients with High Lp(a) Announced by Silence Therapeutics
March 13, 2024 — Silence Therapeutics has announced positive topline 36-week data from the ongoing ALPACAR-360 phase 2…
Read More
Silk Road Medical, Inc., a company focused on reducing the risk of stroke and its devastating impact, today announced that it has launched its Tapered ENROUTE Transcarotid Stent System to hospitals in the United States
March 12, 2024
New Late-breaking Data from Medtronic Evolut Low Risk Trial Demonstrate Strong Clinical and Cost-effectiveness Benefits of TAVR Platform
March 12, 2024 — Medtronic plc, a global leader in healthcare technology, today announced two late-breaking data…
Read More
Physicians at Vilnius University Hospital. Silk Road Medical, Inc., a company focused on reducing the risk of stroke and its devastating impact, today announced that it has launched its Tapered ENROUTE Transcarotid Stent System to hospitals in the United States
March 12, 2024
Stereotaxis Announces Regulatory Submissions of the MAGiC Ablation Catheter in Europe and the United States
March 12, 2024 — Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now